Intervention effects of different brands of botulinum toxin type A on Meige syndrome with anxiety symptoms

1

Botulinum toxin type A is the primary pharmacological treatment for Meige syndrome, which often co-occurs with anxiety symptoms.
2

A study involving 148 patients compared the effects of Hengli and Botox formulations of botulinum toxin type A on Meige syndrome.
3

No significant differences were found in treatment efficacy, duration of effect, or mental state improvements between the two botulinum toxin brands.
4

Both formulations demonstrated similar safety profiles, with no notable disparities in adverse effects reported among patients.
5

The study supports the use of botulinum toxin type A as a safe and effective treatment for Meige syndrome and associated anxiety symptoms.

1